about
Topobiology of human pigmentation: P-cadherin selectively stimulates hair follicle melanogenesisSpermidine promotes human hair growth and is a novel modulator of human epithelial stem cell functionsInflammatory mediator TAK1 regulates hair follicle morphogenesis and anagen induction shown by using keratinocyte-specific TAK1-deficient miceLaminin-511, inducer of hair growth, is down-regulated and its suppressor in hair growth, laminin-332 up-regulated in chemotherapy-induced alopeciaCannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes.Spatial and temporal control of laminin-332 (5) and -511 (10) expression during induction of anagen hair growth.Mutations in TSPEAR, Encoding a Regulator of Notch Signaling, Affect Tooth and Hair Follicle Morphogenesis.Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosis.A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ.Laminin-332 and -511 in skin.Laminin-332-integrin interaction: a target for cancer therapy?Modulation of basophil activity: a novel function of the neuropeptide α-melanocyte-stimulating hormone.Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situ.Endocannabinoids limit excessive mast cell maturation and activation in human skin.Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma.The discovery of epidermal tight junctions.Unique mouse monoclonal antibodies reactive with maturation-related epitopes on type VII collagen.Methods in hair research: how to objectively distinguish between anagen and catagen in human hair follicle organ culture.Allergic contact dermatitis due to adipic polyester in vinyl chloride gloves.Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1.Sorafenib stimulates human skin type mast cell degranulation and maturation.Case of Penicillium marneffei infection in a non-AIDS patient.Case of alopecia induced by sorafenib, possible mechanism similar to alopecia areata.Ultrastructural study of dyschromatosis symmetrica hereditaria with widespread pigmentary eruption.Novel splice site mutation in the LIPH gene in a patient with autosomal recessive woolly hair/hypotrichosis: Case report and published work review.Spatial and temporal control of laminin-332 and -511 expressions during hair morphogenesis.A case of scarring alopecia with Kikuchi-Fujimoto disease.Case of alopecia similar to alopecia areata multilocularis accompanied with neurofibromatosis type 1.Circumscribed palmoplantar hypokeratosis in a barber: Successful treatment using cryotherapy.Case of pseudolymphoma with bald patches on the scalp.Epidermal nevi with aberrant epidermal structure in keratinocytes and melanocytes.Cutaneous consequences of inhibiting EGF receptor signaling in vivo: normal hair follicle development, but retarded hair cycle induction and inhibition of adipocyte growth in Egfr(Wa5) mice.Corticotropin-releasing hormone stimulates the in situ generation of mast cells from precursors in the human hair follicle mesenchyme.Prolactin—a novel neuroendocrine regulator of human keratin expression in situCase of alopecia universalis accompanied by minimal change nephrotic syndromeRe-investigating the Basement Membrane Zone of Psoriatic Epidermal Lesions: Is Laminin-511 a New Player in Psoriasis Pathogenesis?A case of epidermolytic ichthyosis showing a very mild phenotype due to a novel tail extension mutation in KRT10Molecular bases for HOIPINs-mediated inhibition of LUBAC and innate immune responses
P50
Q24310287-39F32E13-1297-436D-8358-0F4ED5A60B1CQ28742091-B85DBFD8-382D-4FCB-9C88-6B3337BD5F67Q33619331-F66C5B82-9AA7-433D-9B79-8A3941E4BF88Q33829487-20426347-ABCB-40DB-A61C-78036B61FB54Q34117612-3E292C3D-ECC3-42A5-B442-959D3003DB6EQ34614518-1E99B06F-6B80-4994-8CCC-A058B9954E6EQ36162463-8CD2E177-2828-4D29-A5FC-7B67F2719BBAQ36371453-DECAD04A-3F60-45B0-AFEC-4953A9454C99Q36773315-B1522805-BA55-46BF-AEFE-79FE06CA1799Q37161422-3815E86C-941A-42D4-97F3-2D70B75D9868Q37239714-DBA24E09-084F-45C9-AAF7-145D9A82779CQ39426552-473B8469-06E7-433E-B4CF-CC6D717BBFDFQ39458872-B92FB63F-2669-42AC-B37D-8434C86E6926Q39666818-C07FC172-7916-46D8-92E6-CE27D31A9BB5Q40321155-F2ABD7F9-2335-4835-A854-22D9ED622149Q42456422-78BD5FDB-00E9-4847-88B5-E94A4BC9A7F5Q42504595-81F5CA25-4A47-49F0-B2DE-2CDCDAF6FCA7Q43281980-A2FE9E25-4922-4438-988C-36FF00A566EEQ46725977-4E8057CF-C79A-4185-BAC9-CCFFD4C86BC2Q46783271-40A1CC24-FEA8-4524-899B-7932608CE157Q47901541-B6436BFA-0953-4C86-9B8F-1893D9D64799Q48126721-634FC8A7-6775-49E7-9FD6-E78181931263Q48302444-EC5E8B08-BBAD-412A-B1D9-B66763F942B1Q48333628-12271F3C-8F24-45F6-B6F7-16A5B744547BQ49719547-C7EEFBD3-8B94-4DD8-A7B4-FC9F3826B500Q50751831-661C5D8F-3369-4EB8-9CB6-22B4C17E655FQ53150939-504454BC-F066-4639-94A3-42E3F88C836FQ53265443-5754645E-96BD-497F-AE0E-0AB8A667176DQ53498514-46D779DF-C0F1-45DF-AEE1-4B5A63055A54Q53552591-C2E74AEC-98DC-4930-85EE-0DE02A942452Q53624766-DBE18EE5-AA9A-4939-9311-5D64548197ACQ54699538-0F841897-89CB-45F9-94F6-C628D634C2C2Q54700834-DC14CF6C-CABF-4B9D-A3A2-2FAD9F555E04Q62659556-7F6F788C-0E6B-4B6D-AADA-92997895BC4BQ85955470-EFF6D825-F028-4016-8DDD-857BAEE7DD35Q89114763-E59856D9-6662-45F2-8809-B96A30804859Q89287850-FBFAC805-BA1B-434D-A265-D8856E759290Q91555628-3FDDE167-03EE-4855-9239-722F5C807049
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Koji Sugawara
@ast
Koji Sugawara
@en
Koji Sugawara
@es
Koji Sugawara
@nl
type
label
Koji Sugawara
@ast
Koji Sugawara
@en
Koji Sugawara
@es
Koji Sugawara
@nl
prefLabel
Koji Sugawara
@ast
Koji Sugawara
@en
Koji Sugawara
@es
Koji Sugawara
@nl
P106
P31
P496
0000-0003-1662-3272